Cardiovascular diseases and the liver

Clinics in Liver Disease

Volumn 15, Issue 1, 2011, Pages 1-20

  Weisberg, Ilan S ^a   Jacobson, Ira M ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Cardiac cirrhosis; Congestive hepatopathy; Ischemic hepatitis

Indexed keywords

ACETYLCYSTEINE; ACTIVIN RECEPTORLIKE KINASE 1; ADENOSINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIURETIC AGENT; ENDOGLIN; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; METHOTREXATE; UNCLASSIFIED DRUG;

ABNORMAL LABORATORY RESULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTERIOVENOUS MALFORMATION; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CONGESTIVE HEPATOPATHY; COOLING; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ECHOCARDIOGRAPHY; FLUID RESUSCITATION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE MUTATION; HEART FAILURE; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEAT STROKE; HEPATITIS; HEPATITIS B; HEPATITIS C; HEPATOMEGALY; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HYPERPYREXIA; HYPOTENSION; ISCHEMIC HEPATITIS; JUGULAR VEIN; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LUNG EMBOLISM; POLYARTERITIS NODOSA; PROGNOSIS; RENDU OSLER WEBER DISEASE; REVIEW; RHABDOMYOLYSIS; SEPSIS; SURVIVAL; ULTRASOUND;

CARDIOVASCULAR DISEASES; FEMALE; HEPATIC ARTERY; HUMANS; LIVER; LIVER CIRCULATION; LIVER DISEASES; MALE; PORTAL VEIN;

EID: 78649510128     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2010.09.010     Document Type: Review

References (118)

1. Lautt W.W., Greenway C.V. Conceptual review of the hepatic vascular bed. Hepatology 1987, 7:952-963.
2. Rappaport A.M. The microcirculatory hepatic unit. Microvasc Res 1973, 6:212-228.
3. Rappaport A.M. Hepatic blood flow: morphologic aspects and physiologic regulation. Int Rev Physiol 1980, 21:1-63.
4. Lautt W.W. Mechanisms and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Phys 1985, 249:549-556.
5. Ezzat W.R., Lautt W.W. Hepatic arterial pressure flow autoregulation is adenosine mediated. Am J Phys 1987, 252:836-845.
6. Smits P., Williams S.B., Lipson D.E., et al. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995, 92:2135-2141.
7. Peralta C., Hotter G., Closa D., et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999, 29:126-132.
8. Gao W.S., Hijioka T., Lindert K.A., et al. Evidence that adenosine is a key component in Carolina rinse responsible for reducing graft failure after orthotopic liver transplantation in the rat. Transplantation 1991, 52:992-998.
9. Zipprich A., Steudel N., Behrmann C., et al. Functional significance of hepatic arterial flow reserve in patients with cirrhosis. Hepatology 2003, 37:385-392.
10. Bynum T.E., Boitnott J.K., Maddrey W.C. Ischemic hepatitis. Dig Dis Sci 1979, 24:129-135.
11. Nouel O., Henrion J., Bernuau J., et al. Fulminant hepatic failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 1980, 25:49-52.
12. Henrion J., Schapira M., Luwaert R., et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003, 82:392-406.
13. Henrion J., Colin L., Schapira M., et al. Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea. J Clin Gastroenterol 1997, 24:245-249.
14. Henrion J., Minette P., Colin L., et al. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 1999, 29:427-433.
15. Mathurin P., Durand F., Ganne N., et al. Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 1995, 109:1682-1684.
16. Ellenberg M., Osserman K.E. The role of shock in the production of central liver cell necrosis. Am J Med 1951, 11:170-178.
17. Killip T., Payne M.A. High serum transaminase in heart disease. Circulatory failure and hepatic necrosis. Circulation 1960, 21:646-660.
18. Clarke W.T. Centrilobular necrosis following cardiac infarction. Am J Pathol 1950, 26:249-255.
19. Cohen J.A., Kaplan M.M. Left-sided heart failure presenting as hepatitis. Gastroenterology 1978, 74:583-587.
20. Giallourakis C.C., Rosenberg P.M., Friedman L.S. The liver in heart failure. Clin Liver Dis 2002, 6:947-967.
21. Seeto R.K., Fenn B., Rockey D.C. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000, 109:109-113.
22. Birgens H.S., Henriksen J., Matzen P., et al. The shock liver. Clinical and biochemical findings in patients with centrilobular necrosis following cardiogenic shock. Acta Med Scand 1978, 204:417-421.
23. Hickman P.E., Potter J.M. Mortality associated with ischaemic hepatitis. Aust N Z J Med 1990, 20:32-34.
24. Fuchs S., Bogomolski-Yahalom V., Paltiel O., et al. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998, 26:183-186.
25. Birrer R., Takuda Y., Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 2007, 46:1063-1070.
26. Henrion J., Descamps O., Luwaert R., et al. Hypoxic hepatitis in patients with cardiac failure. Incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 1994, 21:696-703.
27. Rashed K.A., McNabb W.R., Lewis R.R. Ischaemic hepatitis in the elderly. Gerontology 2002, 48:245-249.
28. Johnson R.D., O'Conner M.L., Kerr R.M. Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol 1995, 90:1244-1245.
29. Whitehead M.W., Hawkes N.D., Hainsworth I., et al. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999, 45:129-133.
30. Gitlin N., Serio K.M. Ischemic hepatitis: widening horizons. Am J Gastroenterol 1992, 87:831-836.
31. Cassidy W.M., Reynolds T.B. Serum lactate dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol 1994, 19:118-121.
32. Fuhrmann V., Madl C., Mueller C., et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006, 131:69-75.
33. Anghern W., Schmid E., Althaus F., et al. Effect of dopamine on hepatosplanchnic flow. J Cardiovasc Pharmacol 1980, 2:257-265.
34. Desai A., Kadleck D., Hufford L., et al. N-Acetylcysteine use in ischemic hepatitis. Am J Ther 2006, 13:80-83.
35. Logan R.G., Mowry F.M., Judge R.D. Cardiac failure simulating viral hepatitis. Three cases with serum transaminase levels above 1,000. Ann Intern Med 1962, 56:784-788.
36. Fuhrmann V., Kneidinger N., Herkner H., et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009, 35:1397-1405.
37. Henrion J., Colin L., Schmitz A., et al. Ischemic hepatitis in cirrhosis: rare but lethal. J Clin Gastroenterol 1993, 16:35-39.
38. Pauwels A., Levy V.G. Ischemic hepatitis in cirrhosis: not so rare, not always lethal. J Clin Gastroenterol 1993, 17:88-89.
39. Sherlock S. The liver in heart failure. Relation of anatomical, functional, and circulatory changes. Br Heart J 1951, 13:273-281.
40. Dunn G.D., Hayes P., Breen K.J., et al. The liver in congestive heart failure: a review. Am J Med Sci 1973, 265:174-189.
41. Meyers R.P., Cerini R., Sayegh R., et al. Cardiac hepatopathy: clinical, hemodynamic and histologic characteristics and correlations. Hepatology 2003, 37:393-400.
42. Lau G.T., Tan H.C., Kritharides L. Type of liver dysfunction in heart failure and its relation to severity of tricuspid regurgitation. Am J Cardiol 2002, 90:1405-1409.
43. Allen L.A., Felker G.M., Pocock, et al. Liver function abnormalities and outcomes in patients with chronic heart failure: results from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur Heart J 2009, 11:170-177.
44. Van Deursen V.M., Damman K., Hillege H.L., et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 2010, 16:84-90.
45. Gelow J.M., Desai A.S., Hochberg C.P., et al. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail 2010, 3:59-64.
46. Luna A., Meister H.P., Szanto P.B. Esophageal varices in the absence of cirrhosis. Incidence and characteristics in congestive heart failure and neoplasm of the liver. Am J Clin Pathol 1968, 49:710-717.
47. Richman S.M., Delman A.J., Grob D. Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med 1961, 30:211-225.
48. Kubo S.H., Walter B.A., John D.H., et al. Liver function abnormalities in chronic heart failure: influence of systemic hemodynamics. Arch Intern Med 1987, 147:1227-1230.
49. Bessman A.N., Evans J.M. The blood ammonia in congestive heart failure. Am Heart J 1955, 50:715-719.
50. Runyon B.A. Cardiac ascites: a characterization. J Clin Gastroenterol 1988, 10:410-412.
51. Christou L., Economou M., Economou G., et al. Characteristics of ascitic fluid in cardiac ascites. Scand J Gastroenterol 2007, 42:1102-1105.
52. Moulton J.S., Miller B.L., Dodd G.D., et al. Passive hepatic congestion in heart failure: CT abnormalities. AJR Am J Roentgenol 1988, 151:939-942.
53. Holley H.C., Koslin D.B., Berland L.L., et al. Inhomogeneous enhancement of liver parenchyma secondary to passive congestion: contrast-enhanced CT. Radiology 1989, 170:795-800.
54. Gore R.M., Mathieu D.G., White E.M., et al. Passive hepatic congestion: cross-sectional imaging features. Am J Roentgenol 1994, 162:71-75.
55. Safran A.P., Schaffner F. Chronic passive congestion of the liver in man. Electron microscopic study of cell atrophy and intralobular fibrosis. Am J Pathol 1967, 50:447-463.
56. Lefkowitch J.H., Mendez L. Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 1986, 2:313-327.
57. Wanless I.R., Liu J.J., Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995, 21:1232-1237.
58. Parera A., Banares R., Alvarez R., et al. The usefulness of transjugular hepatic biopsy in the evaluation of liver disease in candidates for heart transplantation. Gastroenterol Hepatol 1999, 22:67-71.
59. Hsu R.B., Lin F.Y., Chou N.K., et al. Heart transplantation in patients with extreme right ventricular failure. Eur J Cardiothorac Surg 2007, 32:457-461.
60. Raichlin E., Daly R.C., Rosen C.B., et al. Combined heart and liver transplantation: a single center experience. Transplantation 2009, 88:219-225.
61. Kisloff B., Schaffer G. Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 1976, 21:895-900.
62. Jafri S.M. Hypercoagulability in heart failure. Semin Thromb Hemost 1997, 23:543-545.
63. Frazier O.H., Rose E.A., Oz M.C., et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001, 122:1866-1895.
64. Russell S.D., Rogers J.G., Milano C.A., et al. Renal and hepatic function improve in advanced heart failure patients during continuous flow support with the HeartMate II left ventricular assist device. Circulation 2009, 120:2352-2357.
65. Dichtl W., Vogel W., Dunst K.M., et al. Cardiac hepatopathy before and after heart transplantation. Transpl Int 2005, 18:697-702.
66. Naschitz J.E., Slobodin G., Lewis, et al. Heart disease affecting the liver and liver disease affecting the heart. Am Heart J 2000, 140:111-120.
67. Saner F.H., Heuer M., Meyer M., et al. When the heart kills the liver: acute liver failure in congestive heart failure. Eur J Med Res 2009, 14:541-546.
68. Batin P., Wickens M., McEntegart D., et al. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995, 16:1613-1618.
69. Shinagawa H., Inomata T., Koitabashi T., et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008, 72:364-369.
70. Ghaferi A.A., Hutchins G.M. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005, 129:1348-1352.
71. Mace S., Borkat G., Liebman J. Hepatic dysfunction and cardiovascular abnormalities: occurrence in infants, children, and young adults. Am J Dis Child 1985, 139:60-65.
72. Narkewicz M.R., Sondheimer H.M., Ziegler J.W., et al. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 2003, 36:352-357.
73. Miesewetter C.H., Sheron N., Vettukattill J.J. Hepatic changes in the failing Fontan circulation. Heart 2007, 93:579-584.
74. Camposilvan S., Milanesi O., Stellin G., et al. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 2008, 86:177-182.
75. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
76. Saliba T., Dorkholm S., O'Reilly, et al. Hepatocellular carcinoma in two patients with cardiac cirrhosis. Eur J Gastroenterol Hepatol 2010, 22:889-891.
77. Bouchama A., Knochel J.P. Heat stroke. N Engl J Med 2002, 346:1978-1988.
78. Glazer J.L. Management of heatstroke and heat exhaustion. Am Fam Physician 2005, 71:2133-2140.
79. Rubel L.R., Ishak K.G. The liver in fatal exertional heatstroke. Liver 1983, 3:249-260.
80. Hart G.R., Anderson R.J., Crumpler C.P., et al. Epidemic classical heat stroke: clinical characteristics and course in 28 patients. Medicine 1982, 61:189-197.
81. Dematte J.E., O'Mara K., Buescher J., et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med 1998, 129:173-181.
82. Roswell L.B., Brengelmann G.R., Blackmon J.R., et al. Redistribution of blood flow during sustained high skin temperatures in resting man. J Appl Phys 1970, 28:415-420.
83. Bouchama A., Bridey F., Hammami M.M., et al. Activation of coagulation and fibrinolysis in heatstroke. Thromb Haemost 1996, 76:909-915.
84. Kew M., Bersohn I., Seftel H., et al. Liver damage in heat stroke. Am J Med 1970, 49:192-202.
85. Hassanein T., Razack A., Gavaler J., et al. Heatstroke: its clinical and pathological presentation with particular attention to the liver. Am J Gastroenterol 1992, 87:1382-1389.
86. Feller R.B., Wilson J.S. Hepatic failure in fatal exertional heatstroke. Aust N Z J Med 1994, 24:69.
87. Ichai C., Ciais J.F., Hyvernat, et al. Fatal acute liver failure: a rare complication of exertion-induced heat stroke. Ann Fr Anesth Reanim 1997, 16:64-67.
88. Berger J., Hart J., Millis M., et al. Fulminant hepatic failure from heatstroke requiring liver transplantation. J Clin Gastroenterol 2000, 30:429-431.
89. Hadad E., Ben-Ari Z., Heled Y., et al. Liver transplantation in exertional heat stroke: a medical dilemma. Intensive Care Med 2004, 30:1474-1478.
90. Bianchi L., Ohnacker H., Beck K., et al. Liver damage in heatstroke and its regression. A biopsy study. Hum Pathol 1972, 3:237-248.
91. Kew M.C., Minick O.T., Bahu R.M., et al. Ultrastructural changes in the liver in heatstroke. Am J Pathol 1978, 90:609-618.
92. Giercksky T., Boberg K.M., Farstad I.N., et al. Severe liver failure in exertional heatstroke. Scand J Gastroenterol 1999, 8:824-827.
93. Hassanein T., Perper J.A., Tepperman L., et al. Liver failure occurring as a component of exertional heatstroke. Gastroenterology 1991, 100:1442-1447.
94. Saissy J.M. Liver transplantation in a case of fulminant liver failure after exertion. Intensive Care Med 1996, 22:831.
95. Sein Anand J., Chodorowski Z., Korolkiewicz R.P. Heat stroke complicated by liver failure and hyperbilirubinemia - case report. Przegl Lek 2007, 64:344-345.
96. Weigand K., Riediger C., Stremmel W., et al. Are heat stroke and physical exhaustion underestimated causes of acute hepatic failure?. World J Gastroenterol 2007, 13:306-309.
97. Garcin J.M., Bronstein J.A., Cremades S., et al. Acute liver failure is frequent during heat stroke. World J Gastroenterol 2008, 7:158-159.
98. DeLeve L.D., Valla D.C., Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009, 49:1729-1764.
99. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994, 8:345-351.
100. Johnson D.W., Berg J.N., Baldwin M.A., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996, 13:189-195.
101. Ianora A.A., Memeo M., Sabba C., et al. Hereditary hemorrhagic telangiectasia: multidetector row helical CT assessment of hepatic involvement. Radiology 2004, 230:250-259.
102. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol 2007, 46:499-507.
103. Khalid S.K., Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis 2008, 28:247-258.
104. Buonamico P., Suppressa P., Lenato G.M., et al. Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color-Doppler vs multislice computed tomography study. J Hepatol 2008, 48:811-812.
105. Bayrak-Toydemir P., McDonald J., Markewitz B., et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet 2006, 140:463-470.
106. Blewitt R.W., Brown C.M., Wyatt J.I. The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. Histopathology 2003, 42:265-269.
107. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet, in press, Epub 2009.
108. Caselitz M., Bahr M.J., Bleck J.S., et al. Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT). Hepatology 2003, 37:1139-1146.
109. Wu J.S., Saluja S., Garcia-Tsao G., et al. Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. AJR Am J Roentgenol 2006, 187:399-405.
110. Lerut J., Orlando G., Adam R., et al. Liver transplantation registry for hereditary hemorrhagic telangiectasia: report of the European liver transplant registry. Ann Surg 2006, 244:854-864.
111. Garcia-Tsao G., Gish R.G., Punch J. MELD exception for hereditary hemorrhagic telangiectasia. Liver Transpl 2006, 12:S108-S109.
112. Bose P., Holter J.L., Selby G.B. Bevacizumab in hereditary hemorrhagic telangiectasia. N Engl J Med 2009, 360:2143-2144.
113. Mitchell A., Adams L.A., MacQuillan G., et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 2008, 14:210-213.
114. Gilliland I.C., Manning G.C. Liver abscess and polyarteritis nodosa. Br Med J 1954, 2:294.
115. Cowan R.E., Mallinson C.N., Thomas G.E., et al. Polyarteritis nodosa of the liver: a report of two cases. Postgrad Med J 1977, 53:89-93.
116. Haratake J., Horie A., Furuta A., et al. Massive hepatic infarction associated with polyarteritis nodosa. Acta Pathol Jpn 1988, 38:89-93.
117. Takeshita S., Nakamura H., Kawakami A., et al. Hepatitis B-related polyarteritis nodosa presenting vasculitis in the hepatobiliary system successfully treated with lamivudine, plasmapheresis, and glucocorticoid. Intern Med 2006, 45:145-149.
118. Guillevin L., Mahr A., Callard P., et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005, 84:313-322.